The diabetes cardiovascular outcomes trials and racial and ethnic minority enrollment: impact, barriers, and potential solutions.
糖尿病心血管結果試驗與種族及少數族裔的參與：影響、障礙及潛在解決方案。
Front Public Health 2024-11-11
Call to action: Understanding the differences in the use of SGLT-2 inhibitors and GLP-1 receptor agonists.
行動呼籲：了解 SGLT-2 抑制劑和 GLP-1 受體激動劑的使用差異。
Am J Prev Cardiol 2024-02-10
Ethnic Variations in Cardiovascular and Renal Outcomes From Newer Glucose-Lowering Drugs: A Meta-Analysis of Randomized Outcome Trials.
新型降糖藥物對心血管和腎臟結果的族裔變異：隨機結果試驗的荟萃分析。
J Am Heart Assoc 2023-06-01
Effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on cardiovascular and kidney outcomes in Asian versus White patients with type 2 diabetes mellitus.
糖尿病亞洲人與白人患者使用胰高血糖素樣肽-1受體激動劑和鈉-葡萄糖共轉運輸蛋白-2抑制劑對心血管和腎臟結果的影響。
Diabetes Metab Syndr 2023-07-18
Ethnic/Racial and Geographic Disparities on Major Cardiovascular Events in Glucagon Like Peptide-1 receptor Agonists Trials: A Meta-Analysis.
GLP-1 受體激動劑試驗中主要心血管事件的族裔/種族和地理差異：一項荟萃分析。
Curr Probl Cardiol 2023-12-16
Racial, ethnic and regional differences in the effect of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists on cardiovascular and renal outcomes: a systematic review and meta-analysis of cardiovascular outcome trials.
鈉葡萄糖共同轉運蛋白2抑製劑和葡萄糖樣肽1受體激動劑對心血管和腎臟結果的影響：心血管結果試驗的系統性回顧和荟萃分析中的種族、民族和地區差異。
J R Soc Med 2024-04-22
Race and ethnicity and pharmacy dispensing of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes.
種族、族裔與第2型糖尿病患者中 SGLT2 抑制劑和 GLP-1 受體激動劑的藥局配藥。
Lancet Reg Health Am 2024-05-15
Representation of women and racial minorities in SGLT2 inhibitors and heart failure clinical trials.
SGLT2 抑制劑與心衰竭臨床試驗中女性及種族少數群體的代表性。
Int J Cardiol Heart Vasc 2024-11-06
Racial and ethnic disparities in the uptake of SGLT2is and GLP-1RAs among Medicare beneficiaries with type 2 diabetes and heart failure, atherosclerotic cardiovascular disease and chronic kidney disease, 2013-2019.
2013-2019 年間，擁有 Medicare 的 2 型糖尿病和心臟衰竭、動脈粥樣硬化性心血管疾病及慢性腎病的受益者中，SGLT2i 和 GLP-1RA 的使用種族及族裔差異。
Diabetologia 2024-11-08
Racial and Ethnic Disparities in Prescribing of GLP-1 Receptor Agonists in the United States: A Retrospective Cohort Analysis.
美國 GLP-1 受體激動劑處方中的種族和族裔差異：一項回顧性隊列分析。
medRxiv 2024-11-22